Apimeds Pharmaceuticals US Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Apimeds Pharmaceuticals US Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Matawan
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- APUS
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001894525
- EIN
- 85-1099700
Board of directors
-
Bennett Weintraub · DirectorSince 2025
-
Carol A. O'donnell · DirectorSince 2025
-
Christopher Kim · Director · Chairman and CMOSince 2025
-
Elona Kogan · DirectorSince 2025
-
Erik C. Emerson · Director · Chief Executive OfficerSince 2025
-
Hankil Yoon · DirectorSince 2025
-
Jakap Koo · DirectorSince 2025
Chief executives
Erik C. Emerson
· Chief Executive Officer
Since March 2025
Board connections
1 of this board's directors also sit on 1 other board.
- via Carol A. O'donnell
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 16, 2025 | Christopher Kim Director, Officer (Chairman and CMO) | Grant or award | +250,000 | — | — |
| May 16, 2025 | Erik C. Emerson Director, Officer (Chief Executive Officer) | Grant or award | +750,000 | — | — |
| May 14, 2025 | Christopher Kim Director, Officer (Chairman and CMO) | Open-market purchase | +7,730 | $1.86 | $14,378 |
| May 13, 2025 | Christopher Kim Director, Officer (Chairman and CMO) | Open-market purchase | +19,770 | $1.82 | $35,981 |
| May 12, 2025 | Jakap Koo Director | Open-market purchase | +28,500 | $1.99 | $56,715 |
| May 12, 2025 | Inscobee Inc. 10% owner | Open-market purchase | +500,000 | $4.00 | $2,000,000 |
| May 12, 2025 | Inscobee Inc. 10% owner | Derivative conversion | +182,002 | $2.60 | $473,205 |
| May 12, 2025 | Inscobee Inc. 10% owner | Derivative conversion | +71,090 | $2.60 | $184,834 |
| May 12, 2025 | Inscobee Inc. 10% owner | Derivative conversion | +44,041 | $2.60 | $114,507 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.